1 active trials 1 recruiting 1 Phase 3 1 disease areas 3 changes in 30 days
| Phase 2/3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT06761560 | Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to… | Sickle Cell Disease (SCD) | Recruiting | 2026-08-21 |